Delivery Order SPE2DB22D2218-SPE2DB25FR2ZN
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $6.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,811 delivery order to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120-count units) on September 25, 2025, with completion scheduled for September 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a $1,092.36 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units). This firm fixed-price contract, with an ultimate completion date of September 15, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's location in...
- The Defense Logistics Agency awarded a delivery order valued at $6,406.51 to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120 count) on August 1, 2025, with completion targeted for August 4, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $7,142.54 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Contrave ER 8-90 mg tablets (120 count). This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,616.81 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Contrave ER 8-90 mg tablets (120 count). This is a firm fixed-price delivery order with performance scheduled for completion by August 28, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $2,813.66 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count) on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value transaction within the company's broader pharmaceutical distribution portfolio. The product will be delivered to the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units) with a ceiling value of $9,610.38. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025....
- The Defense Logistics Agency awarded a delivery order valued at $1,061.90 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Contrave ER 8-90 mg tablets (120-unit quantity). This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,012.78 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count) on September 26, 2025, with completion scheduled for September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units) with a ceiling value of $37,570.86. This is a firm fixed-price delivery order with no set-aside designation, executed under a competitive procurement process. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...